The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Stephen G. Worthley
Showing 1-18 of 18 articles
Thirty-day and one-year outcomes of the Navitor transcatheter heart valve in patients with aortic stenosis: the prospective, multicentre, global PORTICO NG Study
Sondergaard L,
Walton AS,
Worthley SG,
Smith D,
Chehab B,
Manoharan G,
Yong G,
Bedogni F,
Bates N,
Reardon M
March 9, 2023 | 10.4244/EIJ-D-22-01108
Transcatheter reshaping of the mitral annulus in patients with functional mitral regurgitation: one-year outcomes of the MAVERIC trial
Worthley SG,
Redwood S,
Hildick-Smith D,
Rafter T,
Whelan A,
De Marco F,
Horrigan M,
Delacroix S,
Gregson J,
Erglis A
January 20, 2021 | 10.4244/EIJ-D-20-00484
Final results from the REPRISE I study: five-year clinical outcomes with the repositionable and fully retrievable LOTUS valve system
Gooley R,
Worthley SG,
Whitbourn R,
Montarello J,
Newcomb A,
Allocco D,
Meredith I
December 7, 2018 | 10.4244/EIJ-D-18-00664
Early commercial experience from transcatheter aortic valve implantation using the Portico™ bioprosthetic valve: 30-day outcomes in the multicentre PORTICO-1 study
Maisano F,
Worthley SG,
Rodés-Cabau J,
Linke A,
Fichtlscherer S,
Schäfer U,
Makkar R,
Fontana G,
Asch F,
Søndergaard L
October 19, 2018 | 10.4244/EIJ-D-18-00343
Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve
Kim U,
Blanke P,
Windecker S,
Kasel AM,
Schäfer U,
Walters D,
Linke A,
Le Breton H,
Schymik G,
Spence M,
Søndergaard L,
Abdel-Wahab M,
Worthley SG,
Tchetche D,
Reichenspurner H,
Ohana M,
Sellers S,
Leipsic J
August 3, 2018 | 10.4244/EIJ-D-17-01040
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I,
Dumonteil N,
Blackman D,
Tchetche D,
Walters D,
Hildick-Smith D,
Manoharan G,
Harnek J,
Worthley SG,
Rioufol G,
Lefèvre T,
Modine T,
Van Mieghem N,
Feldman T,
Allocco D,
Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort
Dumonteil N,
Meredith I,
Blackman D,
Tchetche D,
Hildick-Smith D,
Spence M,
Walters D,
Harnek J,
Worthley SG,
Rioufol G,
Lefèvre T,
Modine T,
Van Mieghem N,
Houle V,
Allocco D,
Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01025
Aortic atheroma burden predicts acute cerebrovascular events after transcatheter aortic valve implantation: insights from volumetric multislice computed tomography analysis
Kataoka Y,
Puri R,
Pisaniello A,
Hammadah M,
Qintar M,
Uno K,
Montarello J,
Nicholls S,
Worthley SG
August 20, 2016 | 10.4244/EIJV12I6A127
Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach
Tzikas A,
Gafoor S,
Meerkin D,
Freixa X,
Cruz-González I,
Lewalter T,
Saw J,
Berti S,
Nielsen-Kudsk J,
Ibrahim R,
Lakkireddy D,
Paul V,
Arzamendi D,
Nietlispach F,
Worthley SG,
Hildick-Smith D,
Thambo J-B,
Tondo C,
Aminian A,
Kalarus Z,
Schmidt B,
Søndergaard L,
Kefer J,
Meier B,
Park J,
Sievert H,
Omran H
April 20, 2016 | 10.4244/EIJV11I13A292
Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery disease
Puri R,
Leong D,
Nicholls S,
Liew G,
Nelson A,
Carbone A,
Copus B,
Wong D,
Beltrame J,
Worthley SG,
Worthley M
April 20, 2015 | 10.4244/EIJV10I12A249
A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trial
Sakata K,
Koo B,
Waseda K,
Nakatani D,
Yock P,
Whitbourn R,
Worthley SG,
Ormiston J,
Webster M,
Wilkins G,
Honda Y,
Meredith I,
Fitzgerald P
March 20, 2015 | 10.4244/EIJY14M08_16
Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study
Meredith I,
Worthley SG,
Whitbourn R,
Antonis P,
Montarello J,
Newcomb A,
Lockwood S,
Haratani N,
Allocco D,
Dawkins K
March 20, 2014 | 10.4244/EIJV9I11A216
Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study
Buysschaert I,
Dubois C,
Dens J,
Ormiston J,
Worthley SG,
McClean D,
Ottervanger J,
Meredith I,
Uren N,
Wijns W,
Whitbourn R,
Mehran R,
Lansky A,
Bichalska M,
Meis S,
Verheye S
September 27, 2013 | 10.4244/EIJV9I5A93
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry
Cuculi F,
Banning AP,
Abizaid A,
Bartorelli A,
Baux A,
Dzavik V,
Ellis S,
Gao R,
Holmes D,
Jeong M,
Legrand V,
Neumann F,
Nyakern M,
Spaulding C,
Stoll H,
Worthley SG,
Urban P
December 30, 2011 | 10.4244/EIJV7I8A152
First-in-human experience with the Medtronic Bifurcation Stent System
Meredith I,
Worthley SG,
Whitbourn R,
Webster M,
Fitzgerald P,
Ormiston J
October 28, 2011 | 10.4244/EIJV7I6A108
Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial
Meredith I,
Worthley SG,
Whitbourn R,
Walters D,
McClean D,
Ormiston J,
Horrigan M,
Wilkins G,
Hendriks R,
Matsis P,
Muller D,
Cutlip D
January 15, 2010
The next-generation Endeavor™ Resolute™ stent: 4-month clinical and angiographic results from the Endeavor™ Resolute™ first-in-man trial
Meredith I,
Worthley SG,
Whitbourn R,
Walters D,
Popma J,
Cutlip D,
Fitzgerald P
May 22, 2007
Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial
Chevalier B,
Serruys P,
Silber S,
Garcia E,
Suryapranata H,
Hauptmann K-E,
Wijns W,
Schuler G,
Fath-Ordoubadi F,
Worthley SG,
Thuesen L,
Meredith I,
Bressers M,
Nagai H,
Paunovic D
February 20, 2007
1
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke